Abstract
Spermatogonial stem cells (SSCs) are testis-specific stem cells, which are the foundation of spermatogenesis and male fertility. Transplanting germ cells including SSCs into the testis of an infertile recipient results in donor-derived spermatogenesis. Germ cell transplantation (GCT) is used to assay SSC activity and to quantify the SSC population. GCT also has the potential to treat infertility caused by cytotoxic treatment of juvenile patients for cancer or other cases of azoospermia. Transplanted SSCs move towards the basal compartment of the seminiferous tubule to colonize, and subsequently undergo mitosis and meiosis to generate sperm. The culture system for germ-line stem (GS) cells is well established for mice and rats, but it still remains challenging to produce complete spermatogenesis from GS cells in vitro. Testicular organ culture systems and emerging pluripotent stem cell technology are expected to provide in vitro spermatogenesis in the future. Successful GCT has been reported in many animal species and autologously in humans, though most xenogenic GCT led to incomplete spermatogenesis. Testicular tissue xenografting provides an alternative to GCT, in which grafted testicular tissue grows and produces xenogenic sperm in a mouse host. Testicular tissue xenografting is not only valuable for fertility preservation but also useful to investigate testicular growth and the regulatory system of spermatogenesis and to evaluate the toxicity of chemical substances and drugs on spermatogenesis. Genetic manipulation of germ cells followed by subsequent transplantation can be applied to basic biological study, animal transgenesis, and potentially gene modification therapy though this still remains controversial. Overall, GCT and testis tissue xenografting, in combination with testicular tissue banking, are expected to provide valuable options for fertility preservation.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
- Spermatogonial stem cell
- Germ cell transplantation
- Male fertility preservation
- Spermatogenesis
- Testis xenografting
- Non-rodent model animal
Introduction
Male infertility is a significant problem in various fields such as human medicine, livestock reproduction, and wildlife conservation. Nowadays almost 7% of men are suffering from infertility [1] and genetically or economically valuable animals do not always naturally produce sperm.
As described in previous chapters, some reproductive techniques such as sperm cryopreservation and intracytoplasmic sperm injection (ICSI) are currently applied to fertility preservation [2]. However, such techniques are only applicable for postpubertal males with some sperm in their testes, and prepubertal individuals at risk of azoospermia have hardly any option to preserve their fertility. Especially, pediatric cancer patients who will undergo gonadotoxic chemotherapies or irradiation are waiting for novel reproductive technologies to preserve their potential to father their own genetic children in the future [3].
Hereafter, we will introduce germ cell transplantation (GCT) as a promising countermeasure against the risk of infertility [4]. This technique is feasible for both prepubertal and postpubertal males , and is expected to overcome current limitations of fertility preservation. The key elements in GCT are spermatogonial stem cells (SSCs), which are testis-specific stem cells at the foundation of spermatogenesis and male fertility [5]. By transplanting germ cell populations, including SSCs, the infertile recipient testis can undergo donor-derived spermatogenesis originating from the transplanted SSCs [6]. Up to the present, GCT has provided valuable insights into the mechanism of SSC maintenance, worked as an efficient assay system for the stem cell potential of SSCs, and opened up novel approaches to fertility preservation.
In this chapter we first briefly review mammalian spermatogenesis, review the development of GCT and the resulting neospermatogenesis in the recipient testis, and describe SSC culture as a procedure preceding GCT. As an alternative method to GCT, we also introduce testis tissue grafting. We will then review current applications of GCT in various fields, and discuss possible future applications of GCT. While the majority of work to date has been performed in mouse models, we will also refer to non-rodent animal models considering the actual applications for biomedical, agricultural, and conservation fields.
Spermatogonial Stem Cell Niche
Spermatogenesis is an intricate and well-organized process to continuously generate large numbers of sperm throughout the reproductive life span . In mammalian species, spermatogenesis originates from spermatogonial stem cells (SSCs ) located within the basal compartment of the seminiferous tubules. Like other tissue-specific stem cells, SSCs are characterized by two distinct abilities, the ability to self-renew and the ability to differentiate. While a subpopulation of SSCs self-renew to maintain a certain SSC population, some differentiate into sperm as they move through seminiferous epithelia, from basal to adluminal compartment [7].
Spermatogenic linage development is regulated by various secreted factors, transcription regulators, and endocrine systems. The balance between self-renewal and differentiation of SSC is mainly regulated by several secreted factors. For example, glial cell line-derived neurotrophic factor (GDNF) and fibroblast growth factor 2 (FGF2) promote self-renewal of SSCs [8,9,10,11], while bone morphogenic protein 4 (BMP4), activin A, and retinoic acid stimulate differentiation of SSCs [12,13,14]. Therefore, the growth factor milieu in the basal compartment is essential for SSC proliferation. Such microenvironment is called “niche ,” and within this niche environment, SSCs are believed to undergo self-renewal to expand their population [15].
The SSC niche is relatively well defined in invertebrate species such as Drosophila [16], but in mammalian testis, SSCs appear to be located randomly along the basement membrane throughout the seminiferous tubule. Recent study has suggested a preferential distribution of SSC to the vascular system and interstitial cell population in vivo [17]. Furthermore, the niche-like environment was detected at the terminal segment of seminiferous tubules [18]. However, the nature of the mammalian SSC niche still remains an enigma.
Germ Cell Transplantation
In 1994, Dr. Ralph Brinster and colleagues developed the method of germ cell transplantation (GCT) in mouse testis and demonstrated the functional identity of SSCs for the first time [4]. In this technique, germ cell populations including SSCs are isolated from the donor animal testis and microinjected into the seminiferous tubules of infertile recipient testes, via efferent ducts [19] or the rete testis [20, 21], and then the recipient testis undergoes donor-derived spermatogenesis to produce sperm (Fig. 20.1). To increase the efficiency of donor-derived spermatogenesis , suppression of endogenous spermatogenesis in recipient testes can be achieved by genetic mutation (W/Wv mouse; [22], Sl/Sld mouse; [23]), focal irradiation [24, 25], or gonadotoxic drug administration (busulfan; [4]). In order to distinguish the transplanted cells in recipient testis, transgenic animals are preferred as donors for experimental purposes. For example, transplanting transgenic donor germ cells into the wild-type recipient testis will facilitate visualization of donor-derived spermatogenesis by fluorescence microscopy.
Successful GCT has also been reported in non-rodent animal models such as bulls [25], cats [26], dogs [27], sheep [28], monkeys [29, 30], goats [31], and pigs [32], and autologously in human [33]. Allogenic GCT trials were also performed between mouse and various animal species such as rats [19, 34], hamsters [35], rabbits and dogs [36], primates [37], bulls [38], and cats [26]. Transplanted germ cells from rat and hamster undergo complete spermatogenesis in host mouse testis, while germ cells from other animal species result in incomplete spermatogenesis. This is presumably because the mouse somatic cells lack the ability of supporting germ cells from phylogenetically distant species.
Even now, GCT is the only way to conclusively identify the stemness of SSC. Importantly, GCT provides a functional and quantitative assay system of SSC activity and population . Considering the principle that only an SSC has the ability to generate and maintain a spermatogenic colony in the infertile recipient testis, each colony is thought to arise from a single SSC [39, 40]. Therefore, total number of transplanted SSCs can be roughly estimated by counting the number of colonies formed in the recipient testis.
Neospermatogenesis
After transplanting germ cells, the recipient testis undergoes donor-derived spermatogenesis [4]. Elucidating the mechanism of neospermatogenesis originating from the transplanted SSCs is important for the improvement of GCT efficiency and for further analyses of regulatory mechanisms in SSCs. The transplanted SSCs move towards the basal compartment of the seminiferous tubule to colonize within the SSC niche. This movement of SSCs is called “homing ,” and the homing efficiency determines the number of donor-derived SSC colonies in the infertile recipient testis [41]. In order to home into the niche environment, SSCs have to interact with Sertoli cells, migrate from lumen to the basal compartment of seminiferous tubule, and attach to the basal membrane of the seminiferous tubule [41].
Colonization efficiency of transplanted SSCs is assumed to be 5–10% in mouse and even lower in other animal species [41, 42]. This is mainly because of the difficulty of passing through the tight junctional areas between Sertoli cells which is called blood-testis barrier (BTB) , and this low homing efficiency of transplanted SSCs has prevented the clinical applications of GCT. To improve the homing efficiency to overcome this limitation, work has been directed at uncovering the mechanism of SSC homing. It has been shown that in the absence of small G proteins called Rac1, SSCs lack the ability to migrate through the BTB , but retain their ability to reinitiate spermatogenesis in the testis. Rac1 modulates the expression of tight junction-associated proteins such as claudin 3 [43]. Secreted chemotactic factors from the niche environment, such as GDNF and C-X-C chemokine ligand 12 (CXCL12), were also implicated in promoting migration of transplanted SSCs from the tubular lumen to the basal compartment of the seminiferous tubule [44, 45]. Also, the adhesion molecule beta-1 integrin on both SSCs and Sertoli cells plays a critical role in the localization of SSCs to the basal membrane [46].
Most of the factors required for successful homing are also crucial in the maintenance of SSCs in vivo. For example, deficiency of beta-1 integrin, Rac1, and CXCL12 signaling via its receptor C-X-C chemokine receptor type 4 (CXCR4) in SSCs impaired the maintenance of SSCs, leading to loss of the germ cell population [43,44,45,46,47]. These findings underscore the importance of the niche environment on germ cell homing and survival. In mice, this homing process occurs in the first week after transplantation, and subsequently donor-derived spermatogenic colonies expand [41]. Due to the conserved homing mechanism among various animal species, homing of SSCs happens even in xenotransplantation. However, species-specific differences in spermatogenic regulatory mechanism prevent complete spermatogenesis from xenotransplanted SSCs [26, 27, 36,37,38].
In mice, after SSCs reach to the basal membrane, transplanted SSCs proliferate to generate monolayered colonies in 1 week–1 month posttransplantation. After 1 month of transplantation, colonized SSCs undergo both mitosis and the resulting cells enter meiosis to generate sperm while expanding their colonies in longitudinal axis of the seminiferous tubule [42, 48, 49]. Thus the length of each colony increases with the passage of time, but the number of the donor-derived colonies decreases gradually after 2 months of transplantation [42]. Most of the homing and colonization mechanisms of transplanted SSCs still remain an enigma, but further understanding of these mechanisms will ultimately lead to successful and efficient clinical applications of GCT.
GS Cell and Testicular Tissue Organ Culture
The culture system of germ cells is well established in mouse, and has provided an SSC propagation system and valuable insights to understand basic regulatory mechanism of SSCs. Cultured germ cells were termed germ-line stem (GS) cells, which were shown to include SSCs as a subpopulation by GCT. GS cells are inducible both from neonate and adult mouse [50, 51], even in feeder-free culture conditions [52, 53]. A crucial role of GDNF for maintaining SSCs in culture was established [50, 51] and soluble GDNF family receptor alpha-1 (GFR alpha-1) is known to enhance the trophic effect of GDNF on GS cells [54]. Recent study has shown that FGF2 can maintain and expand the SSC population in vitro without GDNF [10]. Germ cell purification by FACS or MACS sorting and differential attachment of germ cells and somatic cells to tissue culture plates are effective to prevent the contamination with somatic cells and enable stable long-term GS cell culture.
Up to the present, GS cell culture systems were reported in various animal species including rats [54, 55], hamsters [56], rabbits [57], bulls [25], pigs [58, 59], primates [60, 61], and human [62, 63]. However, it has not been achieved to generate fertile haploid cells from GS cell culture in any animal species. Thus it is still required to transplant GS cells into recipient testes as previously described in order to generate fertility-competent sperm.
While it remains challenging to produce complete spermatogenesis from GS cells all in vitro, an organ culture system with liquid-gas interface can generate functional sperm from neonatal mouse testis in vitro, even after testicular tissue cryopreservation [64]. Long-term spermatogenesis in organ culture from neonatal mice is feasible by using microfluidic devices to mimic in vivo condition [65]. However, the efficiency of spermatogenesis from adult testis is low even in mouse [66], requiring further investigation and system improvements before clinical applications in human patients.
Strikingly, both mouse embryonic stem (ES) cells and induced pluripotent stem (iPS) cells can be induced into primordial germ cell-like cells (PGCLCs) which are capable of spermatogenesis and produce functional sperm when transplanted into infertile recipient mouse testis [67, 68]. Although further study is required to elucidate the properties of PGCLCs, this breakthrough expanded the future possibilities of clinical applications. By translating these results to applications, infertile individuals may be able to regain their fertility in the future.
Testicular Tissue Grafting
Testis tissue xenografting is a feasible method to generate complete spermatogenesis from large animal species in a mouse host. In 2002, complete xenogenic spermatogenesis between large animal species and mouse was first reported by xenografting testicular fragments [69]. In this technique, testicular pieces with a diameter of 0.5–1 mm are obtained from donor and embedded under the back skin of immunodeficient adult mice (Fig. 20.2a). The testicular xenografts increased in size and developed to form seminiferous tubules with all stages of spermatogonic cells (Fig. 20.2b, c). The grafts are then excised, minced, and dispersed to isolate sperm that can be used to obtain viable offspring by ICSI (Fig. 20.2d) [70, 71]. After grafting, testicular tissue grows capillaries to construct a functional circulatory connection between the graft and the recipient mouse [72]. The grafted testicular tissue interacts with hypothalamus and pituitary gland, and undergoes continuous steroidogenesis [24]. Testis xenografting was successfully performed in various animal species, including rodents, carnivores, ungulates, and primates [73]. Although the efficiency of spermatogenesis is different for different donor species, testis grafting is considered an applicable technique for a wide range of animal species.
Importantly, not only fresh testis tissue but also refrigerated or cryopreserved testis tissue can develop complete spermatogenesis when grafted into mice [69]. Therefore, cryopreservation of testicular tissue from human childhood patients, valuable livestock, or endangered species is important for fertility preservation. Some studies have also demonstrated that testicular tissue xenografting is useful to study gonadotoxicity of drugs [74] and endocrine disruptors [75].
Human testicular xenografts from infants or prepubertal boys have been revealed to survive and proliferate with structural integrity of seminiferous tubules in mouse for a long period (6 months), even after cryopreservation, and promote spermatogenesis up to pachytene spermatocyte [76, 77]. In the xenografts from adult human, SSCs and spermatogonia occasionally survived, but no spermatocytes were observed and sclerosis of the xenografted tissue progressed in time [78, 79]. Based on these findings, testicular xenografting can be a powerful tool to examine the early period of gametogenesis in human, as well as to preserve germ cell population from infants or prepubertal individuals, rather than adults. Potentially, this model can also be used for fertility recovery of cryptorchid (undescended testes) individuals, considering that a previous study showed that cryptorchid testis tissue recovered spermatogenesis partially in prepubertal human and completely in horse when grafted into immunocompromised mouse [80, 81].
Testis tissue xenografting provides highly valuable options to explore testicular growth, spermatogenic development, endocrine regulation, and toxicity of various substances on spermatogenesis as well as to maintain and propagate male germ cells for the purpose of fertility preservation.
Applications of GCT
GCT technology can be leveraged into applications in various fields. As mentioned before, GCT serves as a functional and quantitative assay system for SSCs. GCT has contributed not only to identify SSCs, but also to uncover biological features of SSC and mechanism of spermatogenic regulation. Transplantation of gene-manipulated germ cells is considered as an especially useful method for such analysis.
Previous studies demonstrated the feasibility of genetic manipulation of cultured germ cells by using viral vectors in rodents, and the genetically modified germ cells generated fertile transgenic sperm upon transplantation [82,83,84,85]. The genetic manipulation of GS cells is also feasible in non-rodent animal species such as goat [86], dog [87], pig [88], and bull [89]. In consideration of these results, transplantation of genetically modified GS cells can provide a novel approach to transgenesis and gene editing of non-rodent animal species.
Transgenic large animal models play an important role in biomedical research, agriculture, and human disease modeling and are also used to produce biopharmaceutical proteins. Currently, transgenic large animal models are mainly produced by somatic cell nuclear transfer [90, 91]. However, this method has low efficiency and frequently leads to fetal deformity and neonatal mortality associated with nuclear reprogramming [92, 93]. GCT can provide an alternative to overcome these problems and generate transgenic sperm in significantly shorter time compared to somatic cell nuclear transfer. Gene-manipulated germ cells transplanted into the testis subsequently colonize the recipient testis, undergo spermatogenesis, and continuously generate fertile transgenic sperm, which can be used to generate transgenic embryos by in vitro fertilization (IVF) . Up to the present, production of transgenic sperm through GCT was reported in goat and pig, following viral transduction and nonviral transfection, respectively [31, 88]. These studies have provided the foundation of future practical applications of GCT for animal transgenesis.
GCT can also be applied to fertility preservation . GCT technology is expected to provide a fertility preservation option for the patients of Klinefelter syndrome, cryptorchidism, and childhood cancers. Klinefelter syndrome is a disease that causes progressive loss of germ cells along with sexual maturation [94]. Preservation of their SSCs before puberty may give patients the option to obtain their own children in the future. People with cryptorchidism may obtain fertile sperm through GCT as long as SSCs can be successfully extracted and preserved [80]. Prepubertal boys at the risk of infertility due to cytotoxic treatment for cancer may have the option to preserve their fertility by cryopreserving their SSCs in preparation for future GCT. While cancer itself can be the direct cause of infertility [95], chemotheraphy or radiotherapy as a cancer treatment often affects germ cells and causes infertility, especially in childhood cancer survivors [3]. Considering that semen cryopreservation cannot be applied to prepubertal cancer patients at the risk of infertility who require gonadotoxic therapies, testis biopsy and germ cell cryopreservation for future GCT can be an effective alternative to their fertility preservation [96, 97]. Testicular tissue banking is currently available in some programs such as the Fertility Preservation Program of Pittsburgh (http://www.fertilitypreservationpittsburgh.org).
Discussion
Autologous GCT is a potential approach to restore fertility, especially for childhood cancer survivors who have become infertile due to cytotoxic therapies to treat cancer. However, the safety of this strategy has to be evaluated before translating GCT to the human clinic. First, elimination of potential contamination of donor germ cells with malignant cells is necessary before GCT can be considered a safe option [98]. Magnetic or fluorescence-activated MACS/FACS cell sorting systems have been explored for their usefulness to remove cancer cells from the donor cells [99, 100], though an efficient depletion system for the malignant cells is not sufficiently established yet [101]. Also, due to the current limitation of human germ cell isolation and enrichment in vitro, it is difficult to obtain sufficient numbers of germ cells from the donor to use for transplantation. Therefore, the development of in vitro propagation systems for human germ cells has a high significance for the future application of GCT. To date, concerns about safety have prevented the application of GCT in humans, although the production of functional sperm through GCT has already been shown in primate models [29]. To minimize the risk to reintroduce malignant cells into the patient, testis tissue xenografting is a promising method to preserve fertility, as it allows to obtain functional sperm from the xenografts [69]. However, safety concerns regarding xenotransplantation, such as potential for contamination with endogenous retroviruses carried by the recipient, still need to be addressed [102]. To prepare for the further development and future clinical applications of GCT and testis tissue xenografting, testis tissue banking is suggested for children at risk of infertility.
Genetic manipulation of germ cells followed by generation of functional sperm through GCT has been achieved in several animal models and has been suggested as an option for people with heritable genetic mutations to correct the mutation in germ cells, to produce sperm to father healthy children. While this strategy for genetic modification is useful and feasible in livestock, its application to germ-line gene therapy in humans remains controversial because of the ethical issues and possible risks for the offspring.
References
Krausz C. Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab. 2011;25(2):271–85.
Palermo GD, Neri QV, Takeuchi T, Rosenwaks Z. ICSI: where we have been and whdingere we are going. Semin Reprod Med. 2009;27(2):191–201.
Meistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril. 2013;100(5):1180–6.
Brinster RL, Zimmermann JW. Spermatogenesis following male germ-cell transplantation. Proc Natl Acad Sci U S A. 1994;91(24):11298–302.
de Rooij DG, Russell LD. All you wanted to know about spermatogonia but were afraid to ask. J Androl. 2000;21(6):776–98.
Brinster RL, Avarbock MR. Germline transmission of donor haplotype following spermatogonial transplantation. Proc Natl Acad Sci U S A. 1994;91(24):11303–7.
Oatley JM, Brinster RL. The germline stem cell niche unit in mammalian testes. Physiol Rev. 2012;92(2):577–95.
Meng X, Lindahl M, Hyvonen ME, Parvinen M, de Rooij DG, Hess MW, et al. Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science. 2000;287(5457):1489–93.
Goriely A, McVean GA, van Pelt AM, O’Rourke AW, Wall SA, de Rooij DG, et al. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci U S A. 2005;102(17):6051–6.
Takashima S, Kanatsu-Shinohara M, Tanaka T, Morimoto H, Inoue K, Ogonuki N, et al. Functional differences between GDNF-dependent and FGF2-dependent mouse spermatogonial stem cell self-renewal. Stem Cell Rep. 2015;4(3):489–502.
Uchida A, Kishi K, Aiyama Y, Miura K, Takase HM, Suzuki H, et al. In vivo dynamics of GFRalpha1-positive spermatogonia stimulated by GDNF signals using a bead transplantation assay. Biochem Biophys Res Commun. 2016;476(4):546–52.
Pellegrini M, Grimaldi P, Rossi P, Geremia R, Dolci S. Developmental expression of BMP4/ALK3/SMAD5 signaling pathway in the mouse testis: a potential role of BMP4 in spermatogonia differentiation. J Cell Sci. 2003;116(Pt 16):3363–72.
Mithraprabhu S, Mendis S, Meachem SJ, Tubino L, Matzuk MM, Brown CW, et al. Activin bioactivity affects germ cell differentiation in the postnatal mouse testis in vivo. Biol Reprod. 2010;82(5):980–90.
Gely-Pernot A, Raverdeau M, Celebi C, Dennefeld C, Feret B, Klopfenstein M, et al. Spermatogonia differentiation requires retinoic acid receptor gamma. Endocrinology. 2012;153(1):438–49.
Morrison SJ, Spradling AC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 2008;132(4):598–611.
Spradling A, Fuller MT, Braun RE, Yoshida S. Germline stem cells. Cold Spring Harb Perspect Biol. 2011;3(11):a002642.
Yoshida S, Sukeno M, Nabeshima Y. A vasculature-associated niche for undifferentiated spermatogonia in the mouse testis. Science. 2007;317(5845):1722–6.
Aiyama Y, Tsunekawa N, Kishi K, Kawasumi M, Suzuki H, Kanai-Azuma M, et al. A niche for GFRalpha1-positive Spermatogonia in the terminal segments of the seminiferous tubules in hamster testes. Stem Cells. 2015;33(9):2811–24.
Ogawa T, Arechaga JM, Avarbock MR, Brinster RL. Transplantation of testis germinal cells into mouse seminiferous tubules. Int J Dev Biol. 1997;41(1):111–22.
Honaramooz A, Megee SO, Dobrinski I. Germ cell transplantation in pigs. Biol Reprod. 2002;66(1):21–8.
Honaramooz A, Behboodi E, Megee SO, Overton SA, Galantino-Homer H, Echelard Y, et al. Fertility and germline transmission of donor haplotype following germ cell transplantation in immunocompetent goats. Biol Reprod. 2003;69(4):1260–4.
Ogawa T, Dobrinski I, Avarbock MR, Brinster RL. Transplantation of male germ line stem cells restores fertility in infertile mice. Nat Med. 2000;6(1):29–34.
Shinohara T, Brinster RL. Enrichment and transplantation of spermatogonial stem cells. Int J Androl. 2000;23(Suppl 2):89–91.
Schlatt S, Kim SS, Gosden R. Spermatogenesis and steroidogenesis in mouse, hamster and monkey testicular tissue after cryopreservation and heterotopic grafting to castrated hosts. Reproduction. 2002;124(3):339–46.
Izadyar F, Den Ouden K, Stout TA, Stout J, Coret J, Lankveld DP, et al. Autologous and homologous transplantation of bovine spermatogonial stem cells. Reproduction. 2003;126(6):765–74.
Kim Y, Selvaraj V, Dobrinski I, Lee H, McEntee MC, Travis AJ. Recipient preparation and mixed germ cell isolation for spermatogonial stem cell transplantation in domestic cats. J Androl. 2006;27(2):248–56.
Kim Y, Turner D, Nelson J, Dobrinski I, McEntee M, Travis AJ. Production of donor-derived sperm after spermatogonial stem cell transplantation in the dog. Reproduction. 2008;136(6):823–31.
Herrid M, Vignarajan S, Davey R, Dobrinski I, Hill JR. Successful transplantation of bovine testicular cells to heterologous recipients. Reproduction. 2006;132(4):617–24.
Hermann BP, Sukhwani M, Winkler F, Pascarella JN, Peters KA, Sheng Y, et al. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell. 2012;11(5):715–26.
Jahnukainen K, Ehmcke J, Quader MA, Saiful Huq M, Epperly MW, Hergenrother S, et al. Testicular recovery after irradiation differs in prepubertal and pubertal non-human primates, and can be enhanced by autologous germ cell transplantation. Hum Reprod. 2011;26(8):1945–54.
Zeng W, Tang L, Bondareva A, Luo J, Megee SO, Modelski M, et al. Non-viral transfection of goat germline stem cells by nucleofection results in production of transgenic sperm after germ cell transplantation. Mol Reprod Dev. 2012;79(4):255–61.
Zheng Y, Tian X, Zhang Y, Qin J, An J, Zeng W. In vitro propagation of male germline stem cells from piglets. J Assist Reprod Genet. 2013;30(7):945–52.
Radford J. Restoration of fertility after treatment for cancer. Horm Res. 2003;59(Suppl 1):21–3.
Clouthier DE, Avarbock MR, Maika SD, Hammer RE, Brinster RL. Rat spermatogenesis in mouse testis. Nature. 1996;381(6581):418–21.
Ogawa T, Dobrinski I, Avarbock MR, Brinster RL. Xenogeneic spermatogenesis following transplantation of hamster germ cells to mouse testes. Biol Reprod. 1999;60(2):515–21.
Dobrinski I, Avarbock MR, Brinster RL. Transplantation of germ cells from rabbits and dogs into mouse testes. Biol Reprod. 1999;61(5):1331–9.
Nagano M, McCarrey JR, Brinster RL. Primate spermatogonial stem cells colonize mouse testes. Biol Reprod. 2001;64(5):1409–16.
Oatley JM, de Avila DM, McLean DJ, Griswold MD, Reeves JJ. Transplantation of bovine germinal cells into mouse testes. J Anim Sci. 2002;80(7):1925–31.
Zhang X, Ebata KT, Nagano MC. Genetic analysis of the clonal origin of regenerating mouse spermatogenesis following transplantation. Biol Reprod. 2003;69(6):1872–8.
Kanatsu-Shinohara M, Inoue K, Miki H, Ogonuki N, Takehashi M, Morimoto T, et al. Clonal origin of germ cell colonies after spermatogonial transplantation in mice. Biol Reprod. 2006;75(1):68–74.
Nagano MC. Homing efficiency and proliferation kinetics of male germ line stem cells following transplantation in mice. Biol Reprod. 2003;69(2):701–7.
Nagano M, Avarbock MR, Brinster RL. Pattern and kinetics of mouse donor spermatogonial stem cell colonization in recipient testes. Biol Reprod. 1999;60(6):1429–36.
Takashima S, Kanatsu-Shinohara M, Tanaka T, Takehashi M, Morimoto H, Shinohara T. Rac mediates mouse spermatogonial stem cell homing to germline niches by regulating transmigration through the blood-testis barrier. Cell Stem Cell. 2011;9(5):463–75.
Kanatsu-Shinohara M, Inoue K, Takashima S, Takehashi M, Ogonuki N, Morimoto H, et al. Reconstitution of mouse spermatogonial stem cell niches in culture. Cell Stem Cell. 2012;11(4):567–78.
Yang QE, Kim D, Kaucher A, Oatley MJ, Oatley JM. CXCL12-CXCR4 signaling is required for the maintenance of mouse spermatogonial stem cells. J Cell Sci. 2013;126(Pt 4):1009–20.
Kanatsu-Shinohara M, Takehashi M, Takashima S, Lee J, Morimoto H, Chuma S, et al. Homing of mouse spermatogonial stem cells to germline niche depends on beta1-integrin. Cell Stem Cell. 2008;3(5):533–42.
Niu Z, Goodyear SM, Avarbock MR, Brinster RL. Chemokine (C-X-C) ligand 12 facilitates trafficking of donor Spermatogonial stem cells. Stem Cells Int. 2016;2016:5796305.
Parreira GG, Ogawa T, Avarbock MR, Franca LR, Brinster RL, Russell LD. Development of germ cell transplants in mice. Biol Reprod. 1998;59(6):1360–70.
Ohta H, Yomogida K, Yamada S, Okabe M, Nishimune Y. Real-time observation of transplanted ‘green germ cells’: proliferation and differentiation of stem cells. Develop Growth Differ. 2000;42(2):105–12.
Kanatsu-Shinohara M, Ogonuki N, Inoue K, Miki H, Ogura A, Toyokuni S, et al. Long-term proliferation in culture and germline transmission of mouse male germline stem cells. Biol Reprod. 2003;69(2):612–6.
Kubota H, Avarbock MR, Brinster RL. Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells. Proc Natl Acad Sci U S A. 2004;101(47):16489–94.
Kanatsu-Shinohara M, Miki H, Inoue K, Ogonuki N, Toyokuni S, Ogura A, et al. Long-term culture of mouse male germline stem cells under serum-or feeder-free conditions. Biol Reprod. 2005;72(4):985–91.
Kanatsu-Shinohara M, Inoue K, Ogonuki N, Morimoto H, Ogura A, Shinohara T. Serum- and feeder-free culture of mouse germline stem cells. Biol Reprod. 2011;84(1):97–105.
Ryu BY, Kubota H, Avarbock MR, Brinster RL. Conservation of spermatogonial stem cell self-renewal signaling between mouse and rat. Proc Natl Acad Sci U S A. 2005;102(40):14302–7.
Hamra FK, Chapman KM, Nguyen DM, Williams-Stephens AA, Hammer RE, Garbers DL. Self renewal, expansion, and transfection of rat spermatogonial stem cells in culture. Proc Natl Acad Sci U S A. 2005;102(48):17430–5.
Kanatsu-Shinohara M, Muneto T, Lee J, Takenaka M, Chuma S, Nakatsuji N, et al. Long-term culture of male germline stem cells from hamster testes. Biol Reprod. 2008;78(4):611–7.
Kubota H, Wu X, Goodyear SM, Avarbock MR, Brinster RL. Glial cell line-derived neurotrophic factor and endothelial cells promote self-renewal of rabbit germ cells with spermatogonial stem cell properties. FASEB J. 2011;25(8):2604–14.
Luo J, Megee S, Rathi R, Dobrinski I. Protein gene product 9.5 is a spermatogonia-specific marker in the pig testis: application to enrichment and culture of porcine spermatogonia. Mol Reprod Dev. 2006;73(12):1531–40.
Kuijk EW, Colenbrander B, Roelen BA. The effects of growth factors on in vitro-cultured porcine testicular cells. Reproduction. 2009;138(4):721–31.
Eildermann K, Gromoll J, Behr R. Misleading and reliable markers to differentiate between primate testis-derived multipotent stromal cells and spermatogonia in culture. Hum Reprod. 2012;27(6):1754–67.
Langenstroth D, Kossack N, Westernstroer B, Wistuba J, Behr R, Gromoll J, et al. Separation of somatic and germ cells is required to establish primate spermatogonial cultures. Hum Reprod. 2014;29(9):2018–31.
Sadri-Ardekani H, Mizrak SC, van Daalen SK, Korver CM, Roepers-Gajadien HL, Koruji M, et al. Propagation of human spermatogonial stem cells in vitro. JAMA. 2009;302(19):2127–34.
He Z, Kokkinaki M, Jiang J, Dobrinski I, Dym M. Isolation, characterization, and culture of human spermatogonia. Biol Reprod. 2010;82(2):363–72.
Sato T, Katagiri K, Gohbara A, Inoue K, Ogonuki N, Ogura A, et al. In vitro production of functional sperm in cultured neonatal mouse testes. Nature. 2011;471(7339):504–7.
Komeya M, Kimura H, Nakamura H, Yokonishi T, Sato T, Kojima K, et al. Long-term ex vivo maintenance of testis tissues producing fertile sperm in a microfluidic device. Sci Rep. 2016;6:21472.
Sato T, Katagiri K, Kojima K, Komeya M, Yao M, Ogawa T. In vitro spermatogenesis in explanted adult mouse testis tissues. PLoS One. 2015;10(6):e0130171.
Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell. 2011;146(4):519–32.
Nakaki F, Hayashi K, Ohta H, Kurimoto K, Yabuta Y, Saitou M. Induction of mouse germ-cell fate by transcription factors in vitro. Nature. 2013;501(7466):222–6.
Honaramooz A, Snedaker A, Boiani M, Scholer H, Dobrinski I, Schlatt S. Sperm from neonatal mammalian testes grafted in mice. Nature. 2002;418(6899):778–81.
Nakai M, Kaneko H, Somfai T, Maedomari N, Ozawa M, Noguchi J, et al. Production of viable piglets for the first time using sperm derived from ectopic testicular xenografts. Reproduction. 2010;139(2):331–5.
Kaneko H, Kikuchi K, Tanihara F, Noguchi J, Nakai M, Ito J, et al. Normal reproductive development of pigs produced using sperm retrieved from immature testicular tissue cryopreserved and grafted into nude mice. Theriogenology. 2014;82(2):325–31.
Schlatt S, Westernstroer B, Gassei K, Ehmcke J. Donor-host involvement in immature rat testis xenografting into nude mouse hosts. Biol Reprod. 2010;82(5):888–95.
Arregui L, Dobrinski I. Xenografting of testicular tissue pieces: 12 years of an in vivo spermatogenesis system. Reproduction. 2014;148(5):R71–84.
van den Driesche S, Macdonald J, Anderson RA, Johnston ZC, Chetty T, Smith LB, et al. Prolonged exposure to acetaminophen reduces testosterone production by the human fetal testis in a xenograft model. Sci Transl Med. 2015;7(288):288ra80.
Rodriguez-Sosa JR, Bondareva A, Tang L, Avelar GF, Coyle KM, Modelski M, et al. Phthalate esters affect maturation and function of primate testis tissue ectopically grafted in mice. Mol Cell Endocrinol. 2014;398(1–2):89–100.
Wyns C, Van Langendonckt A, Wese FX, Donnez J, Curaba M. Long-term spermatogonial survival in cryopreserved and xenografted immature human testicular tissue. Hum Reprod. 2008;23(11):2402–14.
Sato Y, Nozawa S, Yoshiike M, Arai M, Sasaki C, Iwamoto T. Xenografting of testicular tissue from an infant human donor results in accelerated testicular maturation. Hum Reprod. 2010;25(5):1113–22.
Schlatt S, Honaramooz A, Ehmcke J, Goebell PJ, Rubben H, Dhir R, et al. Limited survival of adult human testicular tissue as ectopic xenograft. Hum Reprod. 2006;21(2):384–9.
Geens M, De Block G, Goossens E, Frederickx V, Van Steirteghem A, Tournaye H. Spermatogonial survival after grafting human testicular tissue to immunodeficient mice. Hum Reprod. 2006;21(2):390–6.
Wyns C, Curaba M, Martinez-Madrid B, Van Langendonckt A, Francois-Xavier W, Donnez J. Spermatogonial survival after cryopreservation and short-term orthotopic immature human cryptorchid testicular tissue grafting to immunodeficient mice. Hum Reprod. 2007;22(6):1603–11.
Turner RM, Rathi R, Honaramooz A, Zeng W, Dobrinski I. Xenografting restores spermatogenesis to cryptorchid testicular tissue but does not rescue the phenotype of idiopathic testicular degeneration in the horse (Equus Caballus). Reprod Fertil Dev. 2010;22(4):673–83.
Nagano M, Shinohara T, Avarbock MR, Brinster RL. Retrovirus-mediated gene delivery into male germ line stem cells. FEBS Lett. 2000;475(1):7–10.
Nagano M, Watson DJ, Ryu BY, Wolfe JH, Brinster RL. Lentiviral vector transduction of male germ line stem cells in mice. FEBS Lett. 2002;524(1–3):111–5.
Hamra FK, Gatlin J, Chapman KM, Grellhesl DM, Garcia JV, Hammer RE, et al. Production of transgenic rats by lentiviral transduction of male germ-line stem cells. Proc Natl Acad Sci U S A. 2002;99(23):14931–6.
Ryu BY, Orwig KE, Oatley JM, Lin CC, Chang LJ, Avarbock MR, et al. Efficient generation of transgenic rats through the male germline using lentiviral transduction and transplantation of spermatogonial stem cells. J Androl. 2007;28(2):353–60.
Honaramooz A, Megee S, Zeng W, Destrempes MM, Overton SA, Luo J, et al. Adeno-associated virus (AAV)-mediated transduction of male germ line stem cells results in transgene transmission after germ cell transplantation. FASEB J. 2008;22(2):374–82.
Harkey MA, Asano A, Zoulas ME, Torok-Storb B, Nagashima J, Travis A. Isolation, genetic manipulation, and transplantation of canine spermatogonial stem cells: progress toward transgenesis through the male germ-line. Reproduction. 2013;146(1):75–90.
Zeng W, Tang L, Bondareva A, Honaramooz A, Tanco V, Dores C, et al. Viral transduction of male germline stem cells results in transgene transmission after germ cell transplantation in pigs. Biol Reprod. 2013;88(1):27.
Kim KJ, Cho CM, Kim BG, Lee YA, Kim BJ, Kim YH, et al. Lentiviral modification of enriched populations of bovine male gonocytes. J Anim Sci. 2014;92(1):106–18.
Gama Sosa MA, De Gasperi R, Elder GA. Animal transgenesis: an overview. Brain Struct Funct. 2010;214(2–3):91–109.
Piedrahita JA, Olby N. Perspectives on transgenic livestock in agriculture and biomedicine: an update. Reprod Fertil Dev. 2011;23(1):56–63.
Bacci ML. A brief overview of transgenic farm animals. Vet Res Commun. 2007;31(Suppl 1):9–14.
Dinnyes A, Tian XC, Yang X. Epigenetic regulation of foetal development in nuclear transfer animal models. Reprod Domest Anim. 2008;43(Suppl 2):302–9.
Nieschlag E. Klinefelter syndrome: the commonest form of hypogonadism, but often overlooked or untreated. Dtsch Arztebl Int. 2013;110(20):347–53.
Agarwal A, Allamaneni SS. Disruption of spermatogenesis by the cancer disease process. J Natl Cancer Inst Monogr. 2005;34:9–12.
Wyns C, Curaba M, Vanabelle B, Van Langendonckt A, Donnez J. Options for fertility preservation in prepubertal boys. Hum Reprod Update. 2010;16(3):312–28.
Wu X, Goodyear SM, Abramowitz LK, Bartolomei MS, Tobias JW, Avarbock MR, et al. Fertile offspring derived from mouse spermatogonial stem cells cryopreserved for more than 14 years. Hum Reprod. 2012;27(5):1249–59.
Geens M, Goossens E, De Block G, Ning L, Van Saen D, Tournaye H. Autologous spermatogonial stem cell transplantation in man: current obstacles for a future clinical application. Hum Reprod Update. 2008;14(2):121–30.
Fujita K, Ohta H, Tsujimura A, Takao T, Miyagawa Y, Takada S, et al. Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J Clin Invest. 2005;115(7):1855–61.
Fujita K, Tsujimura A, Miyagawa Y, Kiuchi H, Matsuoka Y, Takao T, et al. Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy. Cancer Res. 2006;66(23):11166–71.
Dovey SL, Valli H, Hermann BP, Sukhwani M, Donohue J, Castro CA, et al. Eliminating malignant contamination from therapeutic human spermatogonial stem cells. J Clin Invest. 2013;123(4):1833–43.
Meije Y, Tonjes RR, Fishman JA. Retroviral restriction factors and infectious risk in xenotransplantation. Am J Transplant. 2010;10(7):1511–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Uchida, A., Dobrinski, I. (2018). Germ Cell Transplantation and Neospermatogenesis. In: Majzoub, A., Agarwal, A. (eds) The Complete Guide to Male Fertility Preservation. Springer, Cham. https://doi.org/10.1007/978-3-319-42396-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-42396-8_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42395-1
Online ISBN: 978-3-319-42396-8
eBook Packages: MedicineMedicine (R0)